2006
DOI: 10.1016/j.ejpb.2006.03.009
|View full text |Cite
|
Sign up to set email alerts
|

Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
138
0
5

Year Published

2008
2008
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 254 publications
(158 citation statements)
references
References 23 publications
0
138
0
5
Order By: Relevance
“…Acrylate polymers are well known skin adhesives [29,30,65]. Our films are composed of chitosan and a PAA but the amount of PAA is only approximately one third of the total polymer weight, a fact that justifies the small values measured for the PAF and WA, see Table 2.…”
Section: Bioadhesionmentioning
confidence: 92%
See 3 more Smart Citations
“…Acrylate polymers are well known skin adhesives [29,30,65]. Our films are composed of chitosan and a PAA but the amount of PAA is only approximately one third of the total polymer weight, a fact that justifies the small values measured for the PAF and WA, see Table 2.…”
Section: Bioadhesionmentioning
confidence: 92%
“…Skin adhesion is one of the most important functional properties for a skin drug delivery system [29] and should be evaluated in all formulations in development for this purpose. The in vitro conditions do not represent the performance of a film under in vivo conditions due to skin properties, such as moisture and elasticity that are not possible to reproduce in the in vitro test.…”
Section: Bioadhesionmentioning
confidence: 99%
See 2 more Smart Citations
“…Poor adhesion has also been reported as a limitation with respect to the use of transdermal patches [138,[204][205].…”
Section: Discussionmentioning
confidence: 99%